-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$78.7860.51% Upside
Legend Biotech Corporation Frequently Asked Questions
-
What analysts cover Legend Biotech Corporation?
Legend Biotech Corporation has been rated by research analysts at Piper Sandler, Truist Financial, Deutsche Bank, Morgan Stanley, RBC Capital, Scotiabank in the past 90 days.